Dr. Cesar Morcillo Serra discusses digital health initiatives at Hospital Cima Sanitas in Barcelona, where he has implemented several digital tools like telemonitoring, video consultations, and chatbots. During the COVID-19 pandemic, these tools helped provide care while avoiding overcrowding and allowed remote monitoring of patients. Dr. Morcillo believes digital therapeutics have potential to help manage chronic diseases but barriers include regulatory issues and gaining acceptance from healthcare professionals. Artificial intelligence and data analysis from digital tools could help control future pandemics by identifying at-risk groups and predicting spread.

1. EMEA (/emea) Digital Health (/topics/digital-health)
Q&A: 'Digital transformation must focus
on both the patient and the healthcare
professional'
MobiHealthNews talks about the value of digital therapeutics, artificial intelligence
and learnings from COVID-19 with Dr. Cesar Morcillo Serra, director of internal
medicine in Hospital Cima Sanitas Barcelona, Spain.
By Aline Noizet (/author/aline-noizet) April 29, 2020 02:16 am
SHARE
Dr. Morcillo is the director of internal medicine Hospital Cima Sanitas
(https://www.hospitalcima.es/en/) in Barcelona and the medical director of Sanitas
digital hospital. He is an active advocate and user of digital technologies in his daily
practice. He will join the HIMSS & Health 2.0 European Digital Event (7-11 September
2020) (https://www.himss.org/event-himss-europe-digital) as an expert in the
session on digital therapeutics
(https://www.himsseuropeconference.eu/helsinki/2020/session/digital-
therapeutics).
The below Q&A has been edited for length and clarity.
You have been a pioneer in using digital tools at Hospital Cima. Can you share some
of the initiatives you have implemented recently?
1

2. Over the past two years we've been implementing multiple projects, thanks to two
innovation platforms developed by Sanitas: Bedigit-AllBedigit-Al (https://bedigit-
all.com/)l that seeks to promote entrapreneurship among employees, and Sanitas
Disruptive (http://www.disruptiveprogram.es/en/index.html), which aims
to attract startup talent in areas such as prevention and genomics, liquid hospital,
artificial intelligence, blockchain, data & analytics and robotics.
Multiple pilot projects have been scaled within the hospital, such as autocheck-in
and geolocation inside the hospital, our connected health platform for
telemonitoring patients with wearables, a video-consultation platform and chat with
the healthcare professionals, chatbot, tablets in the hospital’s rooms, monitoring of
neonatal with cameras in the incubators, digital hospital at home, use of virtual
assistants for the management of electronic medical records or digital technology
validation platform among others.
You will join us at HIMSS & Health 2.0 European Digital Event (7-11
HIMSS & Health 2.0 European Digital Event (7-11
September 2020)
September 2020) (https://www.himss.org/event-himss-europe-digital)
(https://www.himss.org/event-himss-europe-digital) as
an expert in the session on digital therapeutics
digital therapeutics
(https://www.himsseuropeconference.eu/helsinki/2020/session/digital-
(https://www.himsseuropeconference.eu/helsinki/2020/session/digital-
therapeutics)
therapeutics). Do you think it can help physicians in their daily work?
Digital therapeutics (DTx) have a great potential for healthcare professionals as well
as for patients. They can be used independently or with other therapies, medications
or devices and they are available 24/7. One of the benefits of DTx solutions is that
they can collect lots of real world data about the users. The healthcare professionals
can use data to adjust the patients’ therapies, offering both a better experience and
better health outcomes to the patients and end users. I think that DTx solutions are
especially useful for the management of chronic diseases, allowing patients to be
better educated about their disease, empowering them and increasing adherence to
the treatment compliance. For healthcare professionals, DTx facilitates the remote
monitoring of the patients, while offering a better overview of the patient’s health
and the evolution of their disease.
Where do you see the most potential for DTx?
DTx solutions have the potential to treat many diseases, especially those with no
current treatment, to address unmet medical needs, to expand healthcare access, to
empower patients, and to improve clinical and economic outcomes.
As a specialist in internal medicine treating patients with chronic diseases, I think
that DTx will help in optimising the treatment of highly prevalent diseases such as
anxiety or depression, diabetes mellitus, high blood pressure and other
cardiovascular diseases, where the lack of health resources makes frequent
monitoring of the disease difficult.
What do you see as the main barriers to scaling up DTx?
Adoption of DTx by healthcare professionals will be one of the main challenges for it
to become mainstream, for sure. DTx must be tested for safety and efficacy in
randomised clinical trials, must get regulatory clearance by the FDA and EC, and must
improve design and usability. Without those conditions, healthcare professionals will
be reluctant to prescribe them. It’s essential for the companies developing DTx to
work with healthcare professionals to engage them and understand the problems
that need to be solved. As a healthcare specialist, I strongly recommend that any DTx
or new technological device to not just be a product, but a complete service that
includes training and monitoring for both healthcare professionals and patients.
Adoption of other digital tools, like telemedicine, are also challenging. Digital
transformation must focus on both the patient and healthcare professionals. People
and culture are the main barriers for the digital transformation of organisations in
any sector. Levers such as training in the development of digital skills, abilities and
knowledge, the incorporation of collaborative tools, the digitisation of internal

3. communication and innovation at work are the keys to driving this transformation.
Furthermore, technology must improve the experience of both the patient and
healthcare professional, by listening and adding value. Physicians and patients need
to be involved early in the product development to help anticipate barriers, facilitate
acceptance, and minimise disruption of the workflows.
You mention the different solutions you have been implementing recently - how did
those tools help you during the COVID-19 pandemic?
Sanitas' commitment to digitisation and integrating it into our day-to-day life has
allowed us to adapt easily to change and COVID-19 has helped to promote all these
digitisation initiatives, and achieve two key goals:
Humanise the social isolation that we are living in, bringing people closer to
each other virtually.
Provide real clinical value, both for the patient and for the
professionals facilitating the continuity of care and access to information,
during these times when it is not possible to travel to the hospital.
Did you introduce additional technologies to tackle the COVID-19 crisis?
We have acquired 3D printers to manufacture PPE, personal protection, and parts for
ventilators.
But what we have done really well is to enhance two existing technologies that we
were already using (https://www.healthcareitnews.com/news/europe/covid-19-
how-coronavirus-crisis-will-change-care-model): the chatbot and, telemedicine.
Chatbot: we added responses about the virus, based on the instructions from the
health authorities. We received more than 500 consultations a day (6,000
consultations in total so far).
Telemedicine: we have promoted video-consultation and telemonitoring:
1. Video-consultation for outpatients: it has been offered free of charge to all
Sanitas’ clients through our own platform, allowing us to manage the video call
from the patient's medical history in a secure way. Remote connection has also
been enabled for all doctors to be able to do video-consultations from their
homes if they wished. We have been doing 5,000 video consultations a day, 10%
more than we did before.
The video consultations have been useful for three very important reasons:
guaranteeing the agile care of all our patients, avoiding the saturation of other
services such as emergencies and maintaining continuity of care, especially in

4. chronic patients, or for example pregnant women. We have created an online
childbirth preparation plan with video-consultation and chat and more than
1,600 attendees have already used the service in the past few weeks.
2. Video-consultation in hospitalised patients: it allows to make a video call
directly from the tablets that we have in all the patients’ rooms in the hospital.
Therefore we don’t have to avoid entering the room if it is not essential,
avoiding exposure contagion of the staff and incidentally saving PPEs.
Unfortunately, 114 Sanitas employees have already been infected and we have
more than 700 in quarantine, so I believe that any measure that can reduce
our own risk of infection is very useful.
3. Telemonitoring: we are using our connected health platform to follow up on all
patients after they are being discharged from the hospital. With our
application, the patient maintains close contact with the medical team, can
make a video-consultation if they have questions and respond daily to health
questionnaires that inform us of how they are doing. If needed, we have been
sending them a pulse oximeter to their home that allows us to track their
blood’s oxygen level. An alert gets generated and sent to the medical team if
there is an issue.
Could AI and data analysis have helped in controlling the spread of the pandemic?
The data generated by applications could be made public, to be analysed by
scientists and researchers looking for links between the disease and certain
populations, predicting which patients may develop serious respiratory disease from
the virus for example. Containment measures would also be supported as it would
be possible to monitor how the virus and lockdown is affecting mental health, and
forecasting how coronavirus cases and deaths will spread across cities and the
potential reasons.
It is a pity that this technology has not been used widely to stop the epidemic, but it
is never too late and we are going to collaborate with partners in the development of
algorithms for detecting the disease with mobile phones and identify signs of a
COVID-19 infection in medical images.
In terms of innovation and health systems, who do you are the best countries to
follow and learn from in the pandemic fight and management?
New Zealand took early action to shut down tourism and imposed a month-long
lockdown on the entire country, limiting coronavirus casualties. Germany has
overseen the largest-scale coronavirus testing programme in Europe, detecting the
virus early enough to isolate and treat patients effectively. Iceland is offering free
coronavirus testing to all its citizens. Belgium, Finland, and Denmark also have had
some of the more successful responses to the COVID-19 pandemic, thanks to
proactive decision-making and better preparation in terms of medical gear and
protective equipment for healthcare staff and the general public.
The Republic of Korea has also been successful so far in containing COVID-19 without
shutting down its economy with innovative technologies. The country’s experience
from the previous SARS outbreak and the more recent MERS in 2015, has enabled
them to anticipate how to fight COVID-19. The learnings in this instace appeared to
be due to:
The fast development of a coronavirus testing kit;
Smart quarantine information system;
Mobile phone technology data for contact tracing;
AI for improving diagnosis efficiency and patient classification; and
Mobile apps for information sharing.
Let’s see what happens with Google and Apple, who that have announced a joint
effort to enable the use of Bluetooth technology to help governments and health
agencies reduce the spread of the virus.

5. ALSO ON MOBIHEALTHNEWS
10 months ago 1 comment
Healthcare VR researchers
say that certain projects
have stalled during the …
In-depth:
In-depth:
Despite
Despite
some
some
hiccups,
hiccups,
…
…
• 10 months ago 1 comment
Sharecare will now be able
to offer MindSciences
programs focused on …
Sharecare
Sharecare
snaps
snaps
up
up
behavioral
behavioral
health
health
…
…
• 2 months ago 1 comment
Elcam Medical will
manufacture Serenno's
urine output monitoring …
Israeli
Israeli
Serenno
Serenno
Medical
Medical
raises
raises
…
…
• 10 months ago 1 comment
The executives also share
details about what patients
can expect from the G7 …
What's
What's
next
next
for
for
Dexcom?
Dexcom?
CEO,
CEO,
CTO
CTO
…
…
• 10 months ago
Of 50 worldwide
apps analyzed in
Medicine, only 16
COVID-19
COVID-19
apps
apps
user
user
data,
data,
but
but
•
Finally, if you could implement any innovation within the hospital that could make a
difference what would it be?
Artificial intelligence to assist patient and healthcare staff in every step of the
decision making process: data collection, analysis, interpretation, recommendation
and treatment delivery. This would allow healthcare staff to save time that we are
currently wasting in bureaucratic tasks, and dedicate ourselves to what is really
important: spending more time on things that brings value to our patients.
Thank you for your time. More information about HIMSS & Health 2.0 European
Digital Event (7-11 September 2020) (https://www.himss.org/event-himss-europe-
digital) can be found here (http://www.himss.org/event-himss-europe-digital).
MobiHealthNews is a HIMSS Media publication.
Tags: Coronavirus (/tag/coronavirus), dtx (/tag/dtx), digital therapeutics
(/tag/digital-therapeutics), COVID-19 (/tag/covid-19), telemedicine
(/tag/telemedicine)
More regional news
(/news/emea/swiss-start-trials-
uv-light-cleaning-robots-make-
air-travel-safer)
Swiss start-up trials UV
light cleaning robots to
make air travel safer
(/news/emea/swiss-
start-trials-uv-light-
cleaning-robots-make-
air-travel-safer)
By
Tammy Lovell (/content/tammy-
lovell)
April 03, 2021
(/news/emea/ai-technology-
detects-ticking-time-bomb-
arteries)
AI technology detects
‘ticking time bomb’
arteries (/news/emea/ai-
technology-detects-
ticking-time-bomb-
arteries)
By
Tammy Lovell (/content/tammy-
lovell)
April 02, 2021
(/news/emea/uae-first-country-
arab-world-begin-
manufacturing-covid-19-vaccine)
UAE first country in Arab
world to begin
manufacturing COVID-19
vaccine
(/news/emea/uae-first-
country-arab-world-
begin-manufacturing-
covid-19-vaccine)
By
Ahmed El Sherif
(/author/ahmed-el-sherif)
April 01, 2021
SHARE View all comments
0
MOBIHEALTHNEWS:
The latest news in digital health delivered daily to
your inbox.
Email
1

6. (/)
© 2021 MobiHealthNews is a publication of HIMSS Media
Submit
MORE NEWS
Healthcare IT News
(https://www.healthcareitnews.com/)
Healthcare IT News Australia
(http://www.healthcareit.com.au/)
Healthcare Finance News
(http://www.healthcarefinancenews.com/)
HIMSS TV
(https://himsstv.brightcovegallery.com/)
MOBIHEALTHNEWS
The latest news in digital health
delivered daily to your inbox.
Email
Submit
CONNECT
Add MobiHealthNews to your
network.
(https://www.facebook.com/MobiHealth
(https://www.linkedin.com/comp
(https://twitter.com/Mo
About (/about) Advertise (/advertise) Contact (/contact) Privacy Policy (/privacy-policy)